Hemodynamic-Guided Management of Heart Failure (CIP-10170)

Brief description of study

The purpose of this research study is to see if a heart pressure sensor called the CardioMEMS™ PA Sensor (referred to as “the device”) within the CardioMEMS™ HF System can improve health outcomes of people with heart failure. This small sensor is implanted into the heart on the tip of a catheter and through a vein. It takes a daily reading of the pulmonary artery pressure, which reflects the pressures within the heart. The pulmonary artery pressure reading is sent to a secure website that your study doctor can see to help him/her adjust your treatment (usually changes in medications). Ideally, this is to be done before the symptoms get too serious. The CardioMEMS™ HF System received FDA approval for patients who have New York Heart Association (NYHA) Class III heart failure and history of a hospitalization for heart failure in the prior year. In this study, the CardioMEMS™ HF System is considered experimental because it will be used for patients who have been assessed as NYHA Class II or NYHA Class IV and for NYHA Class III patients without a hospitalization for heart failure in the last year.

Clinical Study Identifier: s19-00760
ClinicalTrials.gov Identifier: NCT03387813
Principal Investigator: Tajinderpal Saraon.

If you are registered as a volunteer, please login to the dashboard to send referrals.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.